UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
European urology, ISSN 0302-2838, 11/2017, Volume 72, Issue 5, pp. 757 - 769
Desmopressin | LUTS | IPSS | Nocturia | Guidelines | Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology | Severity of Illness Index | Nocturia - drug therapy | Humans | Risk Factors | Lower Urinary Tract Symptoms - physiopathology | Male | Treatment Outcome | Lower Urinary Tract Symptoms - epidemiology | Nocturia - physiopathology | Nocturia - epidemiology | Recovery of Function | Urological Agents - adverse effects | Lower Urinary Tract Symptoms - drug therapy | Lower Urinary Tract Symptoms - diagnosis | Quality of Life | Nocturia - diagnosis | Urological Agents - therapeutic use | Robotic surgery | Medicine, Experimental | Transplantation of organs, tissues, etc | Medical colleges | Medical research | Public health | Index Medicus
Journal Article
Urology (Ridgewood, N.J.), ISSN 0090-4295, 08/2017, Volume 106, pp. 160 - 166
Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology | Prognosis | Follow-Up Studies | Lower Urinary Tract Symptoms - drug therapy | Time Factors | Lower Urinary Tract Symptoms - etiology | Humans | Lower Urinary Tract Symptoms - physiopathology | Male | Prostatic Hyperplasia - drug therapy | Prostatic Hyperplasia - complications | Randomized Controlled Trials as Topic | Urological Agents - therapeutic use | Biological products | Prostate | Analysis | Hypertrophy | Index Medicus
Journal Article
BJU international, ISSN 1464-4096, 04/2015, Volume 115, Issue 4, pp. 508 - 519
epidemiology | economics | BPH | LUTS | quality of life | burden of illness | Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology | Lower Urinary Tract Symptoms - psychology | Prostatic Hyperplasia - psychology | Humans | Middle Aged | Cost of Illness | Lower Urinary Tract Symptoms - physiopathology | Male | Lower Urinary Tract Symptoms - epidemiology | Prostatic Hyperplasia - epidemiology | Young Adult | Prostatic Hyperplasia - economics | Lower Urinary Tract Symptoms - economics | Aged, 80 and over | Quality of Life | Adult | Aged | Prostatic Hyperplasia - physiopathology | United Kingdom - epidemiology | Databases, Factual | Prostate | Hypertrophy | Aging | Mens health | Health services | Urogenital system | Quality of life | Index Medicus
Journal Article
BJU international, ISSN 1464-4096, 02/2008, Volume 101, Issue 3, pp. 319 - 324
ischaemia | perfusion of bladder and prostate | lower urinary tract symptoms | tamsulosin | α‐blocker | Ischaemia | Perfusion of bladder and prostate | Tamsulosin | α-blocker | Lower urinary tract symptoms | Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology | Urinary tract. Prostate gland | Nephrology. Urinary tract diseases | Biological and medical sciences | Medical sciences | Urinary system involvement in other diseases. Miscellaneous | Prostatism - physiopathology | Humans | Middle Aged | Adrenergic alpha-Antagonists - therapeutic use | Male | Case-Control Studies | Prostatic Hyperplasia - complications | Urodynamics - physiology | Prostatism - drug therapy | Swine | Ultrasonography | Urinary Bladder - diagnostic imaging | Adult | Prostate - blood supply | Prostate - physiopathology | Ischemia - diagnostic imaging | Prostatism - diagnostic imaging | Treatment Outcome | Ischemia - physiopathology | Animals | Ischemia - drug therapy | Sulfonamides - therapeutic use | Prostate - diagnostic imaging | Urinary Bladder - physiopathology | Urinary Bladder - blood supply | Aged | Chronic Disease | Index Medicus
Journal Article
Neurourology and urodynamics, ISSN 0733-2467, 04/2017, Volume 36, Issue 4, pp. 854 - 858
NEURAL-CONTROL | MICTURITION | DETRUSOR OVERACTIVITY | SYMPTOMS | NOCTURNAL POLYURIA | MODEL | outflow tract | BLOOD-PRESSURE | central nervous system | ischemia | WOMEN | bladder | CHRONIC BLADDER ISCHEMIA | aging | STRESS-INCONTINENCE | lower urinary tract symptoms | Animals | Aging - physiology | Lower Urinary Tract Symptoms - etiology | Models, Biological | Humans | Lower Urinary Tract Symptoms - physiopathology | Nocturia - physiopathology | Urinary Bladder Diseases - physiopathology | Urinary Tract - physiopathology | Urine | Brain stem | Inflammation | Urinary tract | Sphincter | Substantia alba | Motor task performance | Diurnal | Emotions | Skeletal muscle | Sacrum | Urinary bladder | Ischemia | Etiology | Aging | Blood pressure | Urogenital system | Age | Index Medicus
Journal Article
European urology, ISSN 0302-2838, 2014, Volume 67, Issue 6, pp. 1099 - 1109
Urology | Clinical practice guidelines | Detrusor overactivity | Benign prostatic hyperplasia | Overactive bladder | Nocturnal polyuria | Diagnosis | Lower urinary tract symptoms | Bladder outlet obstruction | Nocturia | Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology | Guidelines as Topic - standards | Diagnosis, Differential | Evidence-Based Practice | Urinalysis | Cystoscopy - methods | Europe | Humans | Middle Aged | Male | Lower Urinary Tract Symptoms - urine | Prostate-Specific Antigen - blood | Prostatic Hyperplasia - complications | Prostate - pathology | Lower Urinary Tract Symptoms - blood | Prostatic Hyperplasia - diagnosis | Lower Urinary Tract Symptoms - etiology | Lower Urinary Tract Symptoms - diagnosis | Aged, 80 and over | Adult | Prostatic Hyperplasia - blood | Aged | Medical colleges | Analysis | Index Medicus
Journal Article
European urology, ISSN 0302-2838, 12/2017, Volume 72, Issue 6, pp. 986 - 997
Male lower urinary tract symptoms | Minimally invasive treatment | Intraprostatic injection | Prostatic urethral lift | Waterjet ablation | Benign prostatic hyperplasia | Convective water vapour energy | Temporary implantable nitinol device | Prostatic artery embolization | Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology | Pore Forming Cytotoxic Proteins - therapeutic use | Prostheses and Implants - adverse effects | Humans | Prostatic Hyperplasia - therapy | Male | Neurotoxins - therapeutic use | Lower Urinary Tract Symptoms - therapy | Embolization, Therapeutic - adverse effects | Bacterial Toxins - therapeutic use | Prostatic Hyperplasia - complications | Botulinum Toxins, Type A - therapeutic use | Injections | Lower Urinary Tract Symptoms - etiology | Ablation Techniques - adverse effects | Minimally Invasive Surgical Procedures | Index Medicus
Journal Article
The Journal of urology, ISSN 0022-5347, 2016, Volume 196, Issue 1, pp. 146 - 152
Journal Article